The August 2026 sunscreen-and-acne update is a U.S. sunscreen ingredient change, not a new acne treatment or acne-specific rule.
The FDA authorized bemotrizinol—a filter that protects against UVA and UVB—for qualifying over-the-counter sunscreens, but this does not prove a product will prevent breakouts. The order took effect on August 9, 2026. New formulas may still reach stores gradually, so acne-prone shoppers should evaluate each finished product rather than the filter alone.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What exactly did the FDA change?
- Why does this matter for acne-prone skin?
- Does bemotrizinol make a sunscreen acne-friendly?
- What does the 2026 acne evidence actually show?
- What should shoppers do next?
What exactly did the FDA change?
The FDA's final order permits bemotrizinol at concentrations up to 6% in qualifying OTC sunscreens. The agency considers it generally recognized as safe and effective, or GRASE, for adults and children aged six months or older, according to the FDA's June 2026 announcement. This authorization expands the filters manufacturers may use to provide broad-spectrum protection.
It does not approve bemotrizinol as an acne treatment or establish special standards for sunscreens marketed to people with acne. The effective date also does not mean every manufacturer can launch a new formula immediately. The final order granted DSM Nutritional Products and its licensees 18 months of marketing exclusivity, as detailed in FDA Final Administrative Order OTC000039.
Why does this matter for acne-prone skin?
Sun protection remains important even though sunscreen does not directly treat acne. Some acne medicines increase sensitivity to ultraviolet light, while sun exposure can worsen the dark marks that remain after spots heal. For acne-prone skin, the American Academy of dermatology recommends a broad-spectrum, water-resistant sunscreen with SPF 30 or higher.
It also advises choosing one labeled "non-comedogenic," meaning formulated not to clog pores, in its acne skin-care guidance. Bemotrizinol may give manufacturers another way to meet UV-protection goals. Acne compatibility, however, must be judged from the complete formula and how an individual's skin responds.
Does bemotrizinol make a sunscreen acne-friendly?
No. FDA authorization addresses whether bemotrizinol may serve as a UV filter under specified conditions; it does not certify every product containing it as non-comedogenic. The product name, SPF, water-resistance claim, and non-comedogenic label therefore remain more useful shopping information than the presence of one filter.
A familiar filter is not automatically unsuitable, and a newly authorized one is not automatically better for acne. Availability is another limit. The FDA says manufacturers determine when permitted bemotrizinol products reach shelves, so the regulatory change does not establish that a new acne-friendly option is already available.
What does the 2026 acne evidence actually show?
One 2026 controlled study compared a named sunscreen with coconut oil in 30 healthy adults. The sunscreen produced fewer microcomedones, or tiny pore blockages, but researchers tested occluded upper-back skin rather than the faces of people with acne. That narrow design cannot show that sunscreens generally prevent breakouts.
It supports a conclusion about one tested product under specific conditions, not an entire ingredient category. A March 2026 correction also revised a frequently cited 1,785-person acne and post-inflammatory-hyperpigmentation study. The sunscreen was not tinted, participants covered Fitzpatrick skin phototypes I through VI, and the two-month regimen combined sunscreen with a dermocosmetic, according to the Journal of Cosmetic Dermatology correction. Because the regimen used both products, its improvements cannot be attributed to sunscreen alone.
What should shoppers do next?
Treat the update as a reason to watch the market, not a reason to replace a sunscreen that already works. When a bemotrizinol product becomes available, check the finished formula against the same practical criteria used for any sunscreen: Keep the rest of your routine steady when trying a new sunscreen so changes are easier to interpret.
If the product consistently coincides with new clogged bumps or irritation, stop using it and return to a formula your skin tolerated. For children under six months, the FDA's bemotrizinol determination does not apply; the order covers people aged six months and older.
- Broad-spectrum protection
- SPF 30 or higher
- Water resistance
- A non-comedogenic label
- Personal tolerance during regular use